Literature DB >> 20811787

The association of protein S Tokushima-K196E with a risk of deep vein thrombosis.

Makoto Ikejiri1, Hideo Wada, Yuko Sakamoto, Naohiko Ito, Junji Nishioka, Kaname Nakatani, Akihiro Tsuji, Norikazu Yamada, Mashio Nakamura, Masaaki Ito, Tsutomu Nobori.   

Abstract

Deep vein thrombosis (DVT) is a multifactorial disease caused by acquired risk factors such as a bed rest, surgery and malignancies. Although the factor V Leiden and the prothrombin-20210G>A mutation do not exist in Japanese populations, a mutation in protein S (PS) Tokushima (K196E) has been attracting attention in Japan. In this study, the genetic contribution of PS Tokushima (K196E) was evaluated in 60 Japanese patients with thrombosis in comparison to 234 healthy volunteers and 88 patients without thrombosis. Genes associated with the response to warfarin, cytochrome P450 2C9 (CYP2C9), vitamin K epoxide reductase complex subunit 1 (VKORC1), and γ-glutamyl carboxylase (GGCX) were also investigated simultaneously. PS Tokushima (K196E) was detected in 6 patients with thrombosis, in 3 without thrombosis and in 3 healthy volunteers, indicating that there is a high frequency of the PS Tokushima (K196E). There were no significant differences of CYP2C9, VKORC1 or GGCX between the patients with and without DVT. Therefore, PS Tokushima (K196E) is an important genetic risk factor for DVT in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811787     DOI: 10.1007/s12185-010-0671-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

1.  Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S.

Authors:  M Makris; M Leach; N J Beauchamp; M E Daly; P C Cooper; K K Hampton; P Bayliss; I R Peake; G J Miller; F E Preston
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

2.  Frequency of protein S deficiency in general Japanese population.

Authors:  T Nomura; E Suehisa; T Kawasaki; A Okada
Journal:  Thromb Res       Date:  2000-12-01       Impact factor: 3.944

3.  Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.

Authors:  T Hayashi; J Nishioka; K Suzuki
Journal:  Biochim Biophys Acta       Date:  1995-12-12

Review 4.  The protein C anticoagulant system: inherited defects as basis for venous thrombosis.

Authors:  B Dahlbäck
Journal:  Thromb Res       Date:  1995-01-01       Impact factor: 3.944

5.  Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans.

Authors:  Harumi Takahashi; Grant R Wilkinson; Edith A Nutescu; Takashi Morita; Marylyn D Ritchie; Maria G Scordo; Vittorio Pengo; Martina Barban; Roberto Padrini; Ichiro Ieiri; Kenji Otsubo; Toshitaka Kashima; Sosuke Kimura; Shinichi Kijima; Hirotoshi Echizen
Journal:  Pharmacogenet Genomics       Date:  2006-02       Impact factor: 2.089

6.  Protein S Tokushima: abnormal molecule with a substitution of Glu for Lys-155 in the second epidermal growth factor-like domain of protein S.

Authors:  T Hayashi; J Nishioka; T Shigekiyo; S Saito; K Suzuki
Journal:  Blood       Date:  1994-02-01       Impact factor: 22.113

7.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

8.  The prevalence of, and molecular defects underlying, inherited protein S deficiency in the general population.

Authors:  Nicholas J Beauchamp; Anne C Dykes; Nirzari Parikh; R Campbell Tait; Martina E Daly
Journal:  Br J Haematol       Date:  2004-06       Impact factor: 6.998

9.  Identification of protein Salpha gene mutations including four novel mutations in eight unrelated patients with protein S deficiency.

Authors:  Hiromi Okada; Akira Takagi; Takashi Murate; Tatsuya Adachi; Koji Yamamoto; Tadashi Matsushita; Junki Takamatsu; Kanji Sugita; Mitsuhiko Sugimoto; Akira Yoshioka; Tomio Yamazaki; Hidehiko Saito; Tetsuhito Kojima
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

Review 10.  Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system.

Authors:  B Dahlbäck
Journal:  Thromb Haemost       Date:  1991-07-12       Impact factor: 5.249

View more
  13 in total

1.  Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum.

Authors:  Reiko Neki; Tomio Fujita; Koichi Kokame; Isao Nakanishi; Masako Waguri; Yuzo Imayoshi; Noriyuki Suehara; Tomoaki Ikeda; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2011-08-03       Impact factor: 2.490

Review 2.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

3.  Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.

Authors:  Masako Ichiyama; Shouichi Ohga; Masayuki Ochiai; Koichi Tanaka; Yuka Matsunaga; Takeshi Kusuda; Hirosuke Inoue; Masataka Ishimura; Tomohito Takimoto; Yui Koga; Taeko Hotta; Dongchon Kang; Toshiro Hara
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

4.  High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism.

Authors:  Makoto Ikejiri; Hideo Wada; Norikazu Yamada; Maki Nakamura; Naoki Fujimoto; Kaname Nakatani; Akimasa Matsuda; Yosihito Ogihara; Takeshi Matsumoto; Yuki Kamimoto; Tomoaki Ikeda; Naoyuki Katayama; Masaaki Ito
Journal:  Int J Hematol       Date:  2016-10-20       Impact factor: 2.490

5.  Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation.

Authors:  Fumiaki Banno; Toshiyuki Kita; José A Fernández; Hiroji Yanamoto; Yuko Tashima; Koichi Kokame; John H Griffin; Toshiyuki Miyata
Journal:  Blood       Date:  2015-08-06       Impact factor: 22.113

Review 6.  Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians.

Authors:  Tong Yin; Toshiyuki Miyata
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

7.  ELISA-Based Detection System for Protein S K196E Mutation, a Genetic Risk Factor for Venous Thromboembolism.

Authors:  Keiko Maruyama; Masashi Akiyama; Koichi Kokame; Akiko Sekiya; Eriko Morishita; Toshiyuki Miyata
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 8.  Thrombophilia in East Asian countries: are there any genetic differences in these countries?

Authors:  Toshiyuki Miyata; Keiko Maruyama; Fumiaki Banno; Reiko Neki
Journal:  Thromb J       Date:  2016-10-04

Review 9.  Activated protein C anticoagulant system dysfunction and thrombophilia in Asia.

Authors:  Naotaka Hamasaki; Hiroyuki Kuma; Hiroko Tsuda
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

10.  Protein S K196E mutation reduces its cofactor activity for APC but not for TFPI.

Authors:  Keiko Maruyama; Masashi Akiyama; Toshiyuki Miyata; Koichi Kokame
Journal:  Res Pract Thromb Haemost       Date:  2018-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.